心力衰竭的心脏冲击的管理:一个国际RAND适当性小组
Stefan Williams1, Antonis Kalakoutas1, Segun Olusanya1
1Perioperative Medicine Department, Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK.
Critical care (London, England)
|April 2, 2024
概括
心脏衰竭与心脏性休克 (HF-CS) 在重症监护中很常见. 专家共识确定了需要更多研究的领域,特别是在HF-CS患者的初始评估,机械支持和断奶方面.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 心血管研究研究心血管研究
背景情况:
- 带有心脏性休克 (HF-CS) 的心力衰竭现在是重症监护室入院的主要原因.
- 现有的临床指导方针和实践并没有通过专门的随机对照试验对HF-CS.得到可靠的信息.
- 急性不补偿性慢性心力衰竭是HF-CS管理的一个具体重点.
研究的目的:
- 确定心脏衰竭与心脏性休克 (HF-CS) 护理的共识和不确定性的领域.
- 引导临床实践,并为未来HF-CS临床试验的设计提供信息.
- 专注于由急性不补偿性慢性心力衰竭引起的HF-CS.
主要方法:
- 召开了一个由16名成员组成的多学科专家小组.
- 使用了经过修改的RAND/UCLA适当性方法.
- 一项包含34个陈述的调查被参与者在1-9级别上匿名评分.
主要成果:
- 20个陈述被评为适当的,14个被评为不适当的.
- 在初始评估,管理,升级到临时机械循环支持 (tMCS) 和从tMCS中断奶方面注意到不确定性.
- 只有关于胸部超声波在立即高频-CS管理中的实用性,才发现了重要的专家分歧.
结论:
- 该研究强调了需要大规模前性注册表和HF-CS临床试验的关键领域.
- 迫切需要证据可靠地告知临床实践和未来的社会指导方针HF-CS.
- 进一步的研究是必不可少的,以改善HF-CS患者的管理和结果.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Heart Failure Drugs: Inotropic Agents
578
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
578
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Blood Pressure Imbalances and Circulatory Shock
773
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
773


